Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma
Open Access
Abstract
Glutamine metabolism is critical both for the proliferation of cancer cells and the activation of CD8T cells to kill cancer cells. We aim to explore the relationship between the glutamine metabolism of CD8T cells and cancer cells and tumor immunity in the tumor microenvironment. In a TCGA cohort, we found that patients with high scores of glutamine-metabolism-related genes showed poor prognoses, and that a high score of glutamine-metabolism-related genes was an independent risk factor for HCC patients. In single-cell RNA-seq data, we found that, in some patients, the glutamine metabolism gene scores of tumor cells were significantly higher than those of CD8T cells, while decreased ratios of CD8-Tef-GZMA and suppressed tumor-killing activity of CD8-Tef-APOC2 were observed. A further genetic dynamics pseudotime analysis suggested that immune remodeling of these two subpopulations was accompanied by metabolic reprogramming. CD8-Tef-APOC2 in the dominant group tended to metabolize exogenous lipids, while the metabolic program of CD8-Tef-GZMA in the nondominant group was characterized by amino acid and endogenous lipid synthesis. In addition, we found that the glutamine metabolism inhibitor JHU083 promoted the proliferation of CD8T cells and improved the efficacy of PD-1 blockers. We proposed a new tool to quantify the glutamine partitioning between tumor cells and CD8T cells, through which the unique immune microenvironment could be identified at the transcriptome level. Furthermore, the simultaneous destruction of the glutamine metabolism in tumor cells and CD8T cells facilitated the enrichment of tumor-infiltrating CD8T cells and enhanced the efficacy of immunotherapy.Keywords
Funding Information
- Science and Technology Department of Sichuan Province (2021YFS0231, 81802778, HR20033, 92059207, 17002)
- National Natural Science Foundation of China (2021YFS0231, 81802778, HR20033, 92059207, 17002)
- Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province (2021YFS0231, 81802778, HR20033, 92059207, 17002)
- National Natural Science Foundation of China (2021YFS0231, 81802778, HR20033, 92059207, 17002)
- Chinese Foundation for Hepatitis Prevention and Control (2021YFS0231, 81802778, HR20033, 92059207, 17002)
This publication has 34 references indexed in Scilit:
- Resistance to PD1/PDL1 checkpoint inhibitionCancer Treatment Reviews, 2017
- S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fateNature, 2016
- Metabolic control of arthritis: Switch pathways to treatScience Translational Medicine, 2016
- PD-1 blockade induces responses by inhibiting adaptive immune resistanceNature, 2014
- Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and ChallengesCancer Research and Treatment, 2013
- Glutamine and glutathione at ICU admission in relation to outcomeClinical Science, 2012
- Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte ActivationThe Journal of Immunology, 2010
- Free fatty acid release from human breast cancer tissue inhibits cytotoxic T-lymphocyte-mediated killingJournal of Lipid Research, 2005
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Fatty acids and the inhibition of mitogen-induced lymphocyte transformation by leukemic serum.The Journal of Immunology, 1983